Novo Nordisk stock jumped Wednesday on better-than-expected fourth-quarter sales, helped by an Ozempic beat.
The post Novo Nordisk Jumps After Ozempic Decidedly Beats. But ‘Periodic Supply Constraints’ Expected. appeared first on Investor’s Business Daily.